Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Understanding the key features of no annual fee cards can help you maximize benefits. Discover what to prioritize for your financial needs.
18,760 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
The 2026 housing market predictions headline a continued stretch of seller pain and tighter credit. This guide breaks...
IBM's latest profit warning sheds light on the strength and limits of AI demand, cloud growth, and enterprise spendin...
PayPal stock has been grabbing headlines with a rapid rise tied to buyout chatter and a strategic turnaround. This gu...
Berkshire Hathaway is changing under Greg Abel, shifting toward concentrated bets on Apple and Alphabet. This article...
A Paychex insider recently moved tens of thousands of shares, prompting questions about the stock’s trajectory. This ...
On July 22, AI-driven hardware names moved the dial as SMCI posted a surprising margin beat and a burst of orders. Th...
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Dig into the drivers behind PAAS earnings and what they reveal about American silver mining. This guide explains how ...
Get a fresh, investor-focused look at hamilton (hg) 2025 earnings. We'll break down revenue engines, margins, and wha...
As Pi Network marks its Open Network’s first anniversary, supporters and critics clash over migration progress and th...
Investors are rechecking fintech momentum as the stock market today, feb. delivers a choppy session. This guide break...